Pharma Deals Review, Vol 2004, No 44 (2004)

Font Size:  Small  Medium  Large

GlaxoSmithKline and NeuroSearch to Investigate CNS Diseases

Business Review Editor

Abstract


GlaxoSmithKline formed a 5 year research and development alliance with NeuroSearch for several research programs for treating CNS diseases such as depression, anxiety and schizophrenia in a deal worth up to €82 M.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.